Angiotensin II receptor blockade : physiological and clinical implications /
edited by Naranjan S. Dhalla ... [et al.].
Boston : Kluwer Academic Publishers, c1998.
xlii, 588 p. : ill. ; 25 cm.
0792381475 (alk. paper)
More Details
added author
Boston : Kluwer Academic Publishers, c1998.
0792381475 (alk. paper)
general note
"The Manitoba Cardiovascular Forum on Angiotensin Receptor Blockade in Winnipeg was convened October 18-20, 1996"--Pref.
catalogue key
Includes bibliographical references and index.
A Look Inside
Main Description
The relationship between angiotensin II and hypertension was established in 1898 when angiotensin II was shown to modulate systemic blood pressure. Over the intervening decades, a complete characterization of the renin-angiotensin system (RAS) has been achieved, and our understanding of its biochemistry and physiology has led to the directed development of agents such as ACE inhibitors and receptor antagonists capable of controlling hypertension. More recently, it was shown that angiotensin II is secreted within certain tissues, and that these tissue-specific systems operate independently of the systemic RAS. The novel concept that angiotensin II regulates a number of cardiovascular processes that are unrelated to blood pressure has renewed the interest of both basic and clinical scientists in angiotensin II. The association between angiotensin II and cardiac growth, in particular, has indicated that therapies currently in use for hypertension may have direct application to the treatment of heart failure. Angiotensin II Receptor Blockade: Physiological and Clinical Implications focuses on the most recent developments in the molecular biology, cellular physiology and structure-function relationships of angiotensin II and its receptors. In addition, this volume covers the current therapeutic uses for angiotensin receptor antagonists and considers their potential future applications. This volume will be a valuable resource for scientists, practising clinicians and students who are attempting to extend their knowledge in the field of hypertension and heart failure, and who are devoted to improving cardiovascular health.
Table of Contents
Pharmacological Interruption of Renin-Angiotensin in Hypertension
Angiotensin Blockade and Cardiovascular Disease
Angiotensin Blockade and Cardiac Hypertrophy and Heart Failure
Angiotensin Blockade and Remodeling of Heart in Myocardial Infarction
Table of Contents provided by Publisher. All Rights Reserved.

This information is provided by a service that aggregates data from review sources and other sources that are often consulted by libraries, and readers. The University does not edit this information and merely includes it as a convenience for users. It does not warrant that reviews are accurate. As with any review users should approach reviews critically and where deemed necessary should consult multiple review sources. Any concerns or questions about particular reviews should be directed to the reviewer and/or publisher.

  link to old catalogue

Report a problem